On selecting mRNA isoform features for profiling prostate cancer.

Area of Science:

• Molecular Biology
• Bioinformatics
• Genomics

Background:

• Alternative splicing of human pre-messenger RNA (pre-mRNA) significantly contributes to proteome diversity.
• Messenger RNA (mRNA) isoforms reflect post-transcriptional processing and offer a comprehensive view of the transcriptome.
• Differential expression of mRNA isoforms is linked to molecular alterations in cells, distinguishing cancerous from normal tissues.

Purpose of the Study:

• To quantify mRNA isoforms for improved distinction between normal and cancerous tissues.
• To identify robust biomarkers for prostate cancer detection using mRNA isoform expression.
• To analyze isoform expression variability between cancer and non-cancer cell lines, and between normal and cancerous prostate tissues.

Main Methods:

• Utilized statistical methods of multiple comparison and a scoring scheme to extract isoform features.
• Rigorously analyzed isoform expression data for variability and heterogeneity.
• Employed complementary feature selection methods, including statistical t-tests and multiple comparison techniques.

Main Results:

• Identified several isoforms with significant differential expression within the same tissue class.
• Successfully identified isoforms with similar expression changes that provided robust class separation for classification.
• Discovered common and disparate feature subsets between multiple comparison methods and t-tests, highlighting the importance of combined approaches.

Conclusions:

• Quantification of mRNA isoforms is a valuable indicator for distinguishing normal from cancerous tissues.
• The combination of complementary statistical methods enhances the selection of informative isoform features for robust classification.
• This approach provides a more complete understanding of transcriptome complexity and its role in disease states.